TWA
TCI Wealth Advisors’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4
| Closed | -$405 | – | 1473 |
|
|
2023
Q1 | $405 | Sell |
4
-70
| -95% | -$7.09K | ﹤0.01% | 2257 |
|
|
2022
Q4 | $8.84K | Buy |
74
+70
| +1,750% | +$8.36K | ﹤0.01% | 1153 |
|
|
2022
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 2476 |
|
|
2022
Q2 | $0 | Sell |
4
-7
| -64% | – | ﹤0.01% | 2438 |
|
|
2022
Q1 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 2125 |
|
|
2018
Q4 | – | Sell |
-3
| Closed | – | – | 1565 |
|
|
2018
Q3 | $0 | Sell |
3
-9
| -75% | – | ﹤0.01% | 1520 |
|
|
2018
Q2 | $1K | Buy |
+12
| New | +$1K | ﹤0.01% | 1337 |
|